Movement Alert|Infleqtion Rises 8.12% in Regular Trading, Updated Q2 Results and Raised Full-Year Revenue Guidance

Market Focus
Aug 21

On August 21, Infleqtion rose 8.12% in regular trading, trading at $13.58/share, with turnover of approximately $62.18 million.

On the news front, Infleqtion announced on August 18 that it updated its second-quarter results following an accounting adjustment related to two contracts that shifted the timing of revenue recognition between periods, with no impact on cash. The company simultaneously raised its full-year revenue outlook to approximately $45.1 million, up from the prior guidance of $43 million, exceeding the analyst consensus estimate of $43 million.

The updated Q2 results showed revenue of $13.5 million, up significantly from $5.3 million a year earlier and beating analyst expectations of $10.6 million. Net loss narrowed to $0.11 per diluted share from a loss of $0.59 per share in the year-ago period. Prior to the adjustment, the company had initially reported Q2 revenue of $12.6 million on August 13 and guided full-year revenue at $43 million.

Infleqtion is dedicated to developing and commercializing quantum technologies, with products spanning quantum sensing, quantum computing, and software applied across defense and security, artificial intelligence, energy optimization, and space applications.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10